Page 137 - லண்டன் பள்ளி ஆஃப் சுகாதாரம் வெப்பமண்டல மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

U.S. pauses use of J&J vaccine over rare blood clots, rollout delayed in Europe By Michael Erman and Manas Mishra Reuters (Reuters) - U.S. federal health agencies on Tuesday recommended pausing use of Johnson & Johnson s COVID-19 vaccine for at least a few days after six women under age 50 developed rare blood clots after receiving the shot, dealing a fresh setback to efforts to tackle the pandemic. Johnson & Johnson said it would delay rollout of the vaccine to Europe, a week after regulators there said they were reviewing rare blood clots in four recipients of the shot in the United States. South Africa also suspended use of J&J s vaccine.

South africaUnited statesUnited kingdomWhite houseDistrict of columbiaCity ofJeff zientsLudwig burgerPeter hendersonPeter marksJanet woodcockJulie steenhuysenManas mishraAmesh adaljaMark potterIan douglas